Navigation und Service

Springe direkt zu:

Service menu




Antimicrobial Resistance Global Surveillance
Helping to Develop AMR Surveillance Systems

Short description

Few countries in Sub-Saharan Africa have surveillance systems for antimicrobial resistance (AMR). This means there are gaps in the data with regard to the bacteria that could affect public health.

This project, in cooperation with TRICE, aims to enhance resistance diagnostics in partner countries by introducing a blood culture diagnostic system. Together with the partners, a lab-based sentinel system is being installed in selected hospitals. Clinical and socio-demographic data are collected in a national surveillance system. There are also plans for regular training of personnel on the ground. These activities build on the existing contacts of the BMBF-funded German-African health research network ANDEMIA.

The activities are initially focused on the neighbouring countries Côte d'Ivoire and Burkina Faso. With additional funding, the project could be expanded to the Congo. South Africa is willing to be a partner in a South-South cooperation. There is already some national surveillance in place there. WHO documents will serve as blueprints for the development of surveillance systems, in particular the “Global Antimicrobial Resistance Surveillance System”, which is currently being drafted.


Partner countries:

Côte d'Ivoire, Burkina Faso, Democratic Republic of the Congo, South African Republic

Partner institutions:

  • Côte d'Ivoire: University Teaching Hospital, University of Bouaké (CHU Bouaké); Central Laboratory of Animal Pathology (LANADA)
  • Burkina Faso: Centre Muraz (CM)
  • Democratic Republic of the Congo: National Institute for Biomedical Research (INRB), University Hospital, University Kinshasa (UH Kin)
  • South African Republic: National Institute for Communicable Diseases (NICD), University of Pretoria (UP)
  • Germany: Institute of Tropical Medicine and International Health, Charité – Universitätsmedizin Berlin (ITMIH/Charité)